Found: 11
Select item for more details and to access through your institution.
Myocarditis associated with COVID-19 vaccination.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00893-1
- By:
- Publication type:
- Article
The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 405, doi. 10.1007/s40264-024-01405-9
- By:
- Publication type:
- Article
Safety Monitoring of COVID‐19 Vaccines: Perspective from the European Medicines Agency.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1223, doi. 10.1002/cpt.2828
- By:
- Publication type:
- Article
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 334, doi. 10.1002/pds.5162
- By:
- Publication type:
- Article
Improving the Safety of Medicines in the European Union: From Signals to Action.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 521, doi. 10.1002/cpt.1678
- By:
- Publication type:
- Article
Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 2, p. 168, doi. 10.1002/pds.4359
- By:
- Publication type:
- Article
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Patient Reporting in the EU: Analysis of EudraVigilance Data.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Literature review of visual representation of the results of benefit-risk assessments of medicinal products.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 3, p. 238, doi. 10.1002/pds.3880
- By:
- Publication type:
- Article
A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 7, p. 667, doi. 10.1002/pds.3636
- By:
- Publication type:
- Article